Aerie Pharmaceuticals Inc

Biotechnology company · Durham, North Carolina, United States

Aerie Pharmaceuticals Inc is a biotechnology company headquartered in Durham, North Carolina, United States. It has reported private securities offerings to the US SEC, most recently $125 million sold in a notice filed in 2014.

Profile compiled from public records. Is this your company? Request a correction or update

Aerie Pharmaceuticals at a glance

Typebiotechnology company

HeadquartersDurham, North Carolina, United States

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1337553

What does Aerie Pharmaceuticals do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $125 million sold (2014).

Frequently asked questions about Aerie Pharmaceuticals

Where is Aerie Pharmaceuticals headquartered?

Aerie Pharmaceuticals Inc is headquartered in Durham, North Carolina, United States.

What does Aerie Pharmaceuticals do?

Aerie Pharmaceuticals Inc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Similar companies

Humacyte, Inc.Durham, North Carolina, United States
Precision Biosciences IncDurham, North Carolina, United States
Xilis, Inc.Durham, North Carolina, United States
Deep Blue Medical Advances, Inc.Durham, North Carolina, United States
inSoma Bio, Inc.Durham, North Carolina, United States
Atsena Therapeutics, Inc.Durham, North Carolina, United States
Scion Neurostim, Inc.Durham, North Carolina, United States
Sapere Bio, Inc.Durham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.